A Quick Look at Today's Ratings for Abercrombie & Fitch(ANF.US), With a Forecast Between $147 to $215
A Quick Look at Today's Ratings for Abercrombie & Fitch(ANF.US), With a Forecast Between $147 to $215
Insmed Analyst Ratings
H.C. Wainwright Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $90
Insmed's Brensocatib Poised for Market Leadership: A Buy Rating Amidst Unthreatening Competition
Abercrombie & Fitch: A Balanced View Amidst Market Challenges – Equal-weight Rating Maintained
Abercrombie & Fitch Analyst Ratings
FTAI Aviation Analyst Ratings
BTIG Initiates FTAI Aviation(FTAI.US) With Buy Rating, Announces Target Price $140
Telsey Advisory Maintains Abercrombie & Fitch(ANF.US) With Buy Rating, Raises Target Price to $208
Abercrombie & Fitch Analyst Ratings
Fabrinet Price Target Raised to $196.00/Share From $171.00 by B. Riley Securities
Jefferies Initiates Fabrinet(FN.US) With Hold Rating, Announces Target Price $250
Analysts Conflicted on These Technology Names: Fabrinet (FN) and Advanced Micro Devices (AMD)
Citi Maintains Abercrombie & Fitch(ANF.US) With Hold Rating, Raises Target Price to $190
Needham Maintains Fabrinet(FN.US) With Buy Rating, Raises Target Price to $280
Truist Financial Maintains Fluor(FLR.US) With Buy Rating
Analysts Offer Insights on Technology Companies: Palo Alto Networks (PANW), Fabrinet (FN) and Kingdee International Software Group Co (OtherKGDEF)
Fabrinet Analyst Ratings
Fluor (FLR) Gets a Hold From Barclays